Alkermes (ALKS) - Stock price history

Stock price history of Alkermes from 1991 to 2025

Annual Stock Price Performance

Year	Performance
2025	-0.42%
2024	0.49%
2023	7.23%
2022	8.20%
2021	17.83%
2020	0.96%
2019	-29.92%
2018	-46.56%
2017	-2.44%
2016	-25.72%
2015	36.30%
2014	45.53%
2013	110.89%
2012	6.81%
2011	38.33%
2010	26.47%
2009	-12.14%
2008	-29.47%
2007	19.10%
2006	-34.84%
2005	36.47%
2004	0.86%
2003	102.70%
2002	-75.65%
2001	-4.58%
2000	23.04%
1999	110.16%
1998	11.64%
1997	-11.17%
1996	210.00%
1995	284.85%
1994	-71.19%
1993	-22.22%
1992	-52.78%
1991	63.64%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Acorda Therapeutics ACOR	£0.49	0.00%	🇺🇸 USA
Bristol-Myers Squibb BMY	£40.29	-0.59%	🇺🇸 USA
Johnson & Johnson JNJ	£152.75	-0.62%	🇺🇸 USA
Pfizer PFE	£18.64	-0.26%	🇺🇸 USA
AstraZeneca AZN	£68.41	0.79%	🇬🇧 UK
Teva Pharmaceutical Industries TEVA	£23.28	0.62%	🇮🇱 Israel
Zogenix ZGNX	£19.78	0.00%	🇺🇸 USA
Sanofi SNY	£35.87	0.73%	🇫🇷 France
Novartis NVS	£103.30	1.80%	🇨🇭 Switzerland

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Alkermes (ALKS)